BCMA-TGF-BETA Insensitive Armored CAR T Cells
Phase I Study of BCMA-TGF-BETA Insensitive Armored CAR T Cells in Patients With Relapsed and/or Refractory Multiple Myeloma
Arms / Cohorts
Experimental:BCMA-TGFβ CAR-T cells (0.50 x10^6 cells/kg)
Not yet accepting
Experimental:BCMA-TGFβ CAR-T cells (0.75 x10^6 cells/kg)
Not yet accepting
Experimental:BCMA-TGFβ CAR-T cells (1 x 10^6 cells/kg)
Not yet accepting
Experimental:BCMA-TGFβ CAR-T cells (2.5 x 10^6 cells/kg)
Not yet accepting
Experimental:BCMA-TGFβ CAR-T cells (Maximum tolerated dose)
Not yet accepting
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.